Ibuprofen Bioavailability Study

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

June 13, 2017

Study Completion Date

June 13, 2017

Conditions
Healthy
Interventions
DRUG

Test - RB ibuprofen acid orodispersible tablets

RB ibuprofen acid orodispersible tablets, 2 x 200 mg, single dose, oral.

DRUG

Reference - RB Nurofen ibuprofen acid tablets

RB Nurofen ibuprofen acid tablets, 2 x 200 mg, single dose, oral.

DRUG

Comparator - Dolormin ibuprofen lysine tablets

Dolormin ibuprofen lysine tablets 2 x 342 mg (each 342 mg tablet contains 200 mg ibuprofen), single dose, oral.

Trial Locations (1)

Unknown

Simbec Research, Merthyr Tydfil

All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

lead

Reckitt Benckiser Healthcare (UK) Limited

INDUSTRY

NCT03180879 - Ibuprofen Bioavailability Study | Biotech Hunter | Biotech Hunter